Research and Devlopment Signalchem Lifesciences Opens a Research Center in Bengaluru

Editor: Dominik Stephan

Signalchem Lifesciences has expanded in the Indian market by opening a facility at Bengaluru. A Richmond-based life sciences company has made important discoveries in cancer, inflammation and central nervous system disorders. Through the newly inaugurated Indian facility, the company aims to convert these early discoveries into drugs for global use.

Related Vendors

(Picture: PROCESS)

Bengaluru/India - Not only will the research facility in Bengaluru will allow the company to address various diseases in different parts of the world, but it also increases the value of the company’s therapies and helps increase its intellectual property.